Key Financial Data Of Group

PhoenixBio Co.,Ltd. - Filing #7297348

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of group
Business results of group
Net sales
788,201,000 JPY
1,715,321,000 JPY
881,757,000 JPY
Ordinary profit (loss)
-123,652,000 JPY
43,526,000 JPY
45,868,000 JPY
Profit (loss) attributable to owners of parent
-124,748,000 JPY
26,378,000 JPY
27,626,000 JPY
Comprehensive income
-123,426,000 JPY
62,184,000 JPY
63,742,000 JPY
Net assets
1,685,117,000 JPY
1,797,607,000 JPY
1,649,595,000 JPY
Total assets
2,534,811,000 JPY
2,715,320,000 JPY
3,176,414,000 JPY
Basic earnings (loss) per share
-30.89
6.98
7.53
Diluted earnings per share
5.22
Equity-to-asset ratio
0.659 xbrli:pure
0.657 xbrli:pure
0.515 xbrli:pure
Net cash provided by (used in) operating activities
-95,184,000 JPY
-79,307,000 JPY
-33,164,000 JPY
Net cash provided by (used in) investing activities
-8,514,000 JPY
115,358,000 JPY
124,312,000 JPY
Net cash provided by (used in) financing activities
-60,338,000 JPY
-244,879,000 JPY
19,646,000 JPY
Cash and cash equivalents
1,204,590,000 JPY
1,384,891,000 JPY
1,722,690,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.